Long-Term Observation of Improvement in Liver Fibrosis Index by A Glucagon-Like Peptide-1 Receptor Agonist in A Patient with Type 2 Diabetes: A Case Report. Archives of Clinical and Medical Case Reports, v. 4, n. 2, p. 292–301, 10 Apr.2020.